Search research articles
Contact Us
Filters
Showing results (61-70 of 84) with videos related to
Page
of 9
Sort By:
Frontiers in Oncology
|
July 30, 2019
Impact of Taxanes, Endocrine Therapy, and Deleterious Germline <i>BRCA</i> Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy
Matteo Lambertini, Nathalie Olympios, Justine Lequesne, et al.
Frontiers in Oncology
|
October 29, 2020
Efficacy and Safety of Controlled Ovarian Stimulation With or Without Letrozole Co-administration for Fertility Preservation: A Systematic Review and Meta-Analysis
Benedetta Bonardi, Claudia Massarotti, Marco Bruzzone, et al.
Cancer Treatment Reviews
|
December 24, 2013
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials
Lucia Del Mastro, Marcello Ceppi, Francesca Poggio, et al.
Cancers
|
October 28, 2023
The Role of Cyclin-Dependent Kinases (CDK) 4/6 in the Ovarian Tissue and the Possible Effects of Their Exogenous Inhibition
Graziana Scavone, Silvia Ottonello, Eva Blondeaux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 5, 2013
Reply to Z. Blumenfeld et al
Isabelle Demeestere, Pauline Brice, Fedro Alessandro Peccatori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2016
No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial
Isabelle Demeestere, Pauline Brice, Fedro A Peccatori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2012
Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial
Isabelle Demeestere, Pauline Brice, Fedro A Peccatori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 29, 2016
Reply to M. Lambertini et al
Isabelle Demeestere, Pauline Brice, Fedro A Peccatori, et al.
Breast (Edinburgh, Scotland)
|
September 1, 2018
The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients
Matteo Lambertini, Massimo Di Maio, Olivia Pagani, et al.
Reproductive Biomedicine Online
|
March 28, 2019
Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in youngBRCA-mutated breast cancer patients
Matteo Lambertini, Massimo Di Maio, Francesca Poggio, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 84) with videos related to
Sort By:
Page
of 9
Frontiers in Oncology
|
July 30, 2019
Impact of Taxanes, Endocrine Therapy, and Deleterious Germline <i>BRCA</i> Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy
Matteo Lambertini, Nathalie Olympios, Justine Lequesne, et al.
Frontiers in Oncology
|
October 29, 2020
Efficacy and Safety of Controlled Ovarian Stimulation With or Without Letrozole Co-administration for Fertility Preservation: A Systematic Review and Meta-Analysis
Benedetta Bonardi, Claudia Massarotti, Marco Bruzzone, et al.
Cancer Treatment Reviews
|
December 24, 2013
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials
Lucia Del Mastro, Marcello Ceppi, Francesca Poggio, et al.
Cancers
|
October 28, 2023
The Role of Cyclin-Dependent Kinases (CDK) 4/6 in the Ovarian Tissue and the Possible Effects of Their Exogenous Inhibition
Graziana Scavone, Silvia Ottonello, Eva Blondeaux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 5, 2013
Reply to Z. Blumenfeld et al
Isabelle Demeestere, Pauline Brice, Fedro Alessandro Peccatori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2016
No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial
Isabelle Demeestere, Pauline Brice, Fedro A Peccatori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2012
Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial
Isabelle Demeestere, Pauline Brice, Fedro A Peccatori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 29, 2016
Reply to M. Lambertini et al
Isabelle Demeestere, Pauline Brice, Fedro A Peccatori, et al.
Breast (Edinburgh, Scotland)
|
September 1, 2018
The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients
Matteo Lambertini, Massimo Di Maio, Olivia Pagani, et al.
Reproductive Biomedicine Online
|
March 28, 2019
Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in youngBRCA-mutated breast cancer patients
Matteo Lambertini, Massimo Di Maio, Francesca Poggio, et al.
Page
of 9